12 development-"https:"-"https:"-"https:"-"https:"-"https:"-"CNRS" PhD positions in France
Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
extracellular vesicles. The delivery of RNA into the cytosol represents a major challenge for the development of new delivery strategies and RNA-based therapies. Indeed, following cellular internalization, RNA
-
Processes (https://simap.grenoble-inp.fr ) - is a multidisciplinary laboratory with more than 200 participants from chemistry, physics, materials and fluid mechanics. It is one of the leading laboratories in
-
Evolution Under Ion Irradiation using transmission electron microscopy. In situ transmission electron microscopy (TEM) is a powerful characterization technique that can be used to provide a comprehensive
-
leading laboratory in optics and nanophotonics. The PhD student will benefit from: - The expertise of the team's PhD students and postdoctoral researchers, who are already involved in the development
-
the extent of glaciers over time using moraine dating and reconstruct the evolution of the glacier fronts of the studied glaciers using a statistical model. • Identify and quantify the influence
-
be carried out in collaboration with Jérôme Chanut, the lead developer of the NEMO model's numerical core at Mercator Ocean International. The NEMO Research & Development team at LOCEAN investigates
-
working for about fifteen years on the development of short-term forecasting systems designed to anticipate these phenomena by a few hours. Better anticipation should allow civil protection and emergency
-
applications. It will be carried out within the Nuclear Structure and Energy (SEN) group at SUBATECH using the newly developed, hybrid Total Absorption Spectrometer (TAS) called STARS. TAGS is the preferred
-
for the development of innovative NK-cell-based immunotherapies. The project combines fundamental immunology with translational research. Research Environment The successful candidate will join the Innate Lymphoid Cell
-
reConnect, Institut Pasteur in Paris. The project will develop next-generation AAV gene therapy and precision genome editing for Usher syndrome, building on unique humanized mouse models and strong in vivo